NCT06386757

Brief Summary

The objective of this study is to compare the effectiveness and safety of video laryngoscopy versus direct laryngoscopy for nasal intubation in patients with maxillofacial fractures regarding less bleeding to oral and nasal structures, quicker intubation times, increased success rates for first intubation attempts, fewer uses of the Magill forceps and the less need for cervical spine extension

Trial Health

57
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
64

participants targeted

Target at P50-P75 for not_applicable

Timeline
Completed

Started Jun 2024

Shorter than P25 for not_applicable

Geographic Reach
1 country

1 active site

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

April 4, 2024

Completed
22 days until next milestone

First Posted

Study publicly available on registry

April 26, 2024

Completed
1 month until next milestone

Study Start

First participant enrolled

June 1, 2024

Completed
7 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

January 1, 2025

Completed
2 months until next milestone

Study Completion

Last participant's last visit for all outcomes

March 1, 2025

Completed
Last Updated

February 21, 2025

Status Verified

May 1, 2024

Enrollment Period

7 months

First QC Date

April 4, 2024

Last Update Submit

February 20, 2025

Conditions

Keywords

nasal intubationvideolaryngscopydirect laryngscopybogie stylet

Outcome Measures

Primary Outcomes (1)

  • Incidence of nasal and oropharyngeal bleeding

    Incidence of nasal and oropharyngeal bleeding using Fromme's ordinal scale which is used for assessment of the surgical field quality( V Rajanigandha, et al. 2023),we will modify this scale to evaluate airway as follows : 0- No bleeding (virtually bloodless field) 1. Minimal bleeding ( not a nuisance to vision , no suctioning required) 2. Mild bleeding (a nuisance to vision but does not compromises laryngeal tube insertion, occasional suctioning required ) 3. Moderate bleeding (slightly compromises laryngeal tube insertion, frequent suctioning required) 4. Severe bleeding (significantly compromises laryngeal tube insertion, frequent suctioning required) 5. Massive bleeding (cannot insert laryngeal tube, constant suctioning required)

    Through study completion, average 60 minutes at 5, 15, 30 minutes

Secondary Outcomes (3)

  • Time of successful intubation, defined as the time from removal of mask ventilation and beginning of bougie insertion until inflation of tube cuff

    Within minutes

  • Overall rate of first trial success.

    Within minutes

  • The use of magill forceps

    Within minutes

Study Arms (2)

Group Ι Combined Video Laryngoscopy (VL) and Bougie

ACTIVE COMPARATOR

Group Ι Combined Video Laryngoscopy (VL) and Bougie: Nasal intubation will be performed using a video laryngoscope and a bougie.

Group ΙI Direct Laryngoscopy (DL) and Bougie :

ACTIVE COMPARATOR

Nasal intubation will be performed using a traditional direct laryngoscope and a bougie.

Procedure: Combined Direct Laryngoscopy (DL) and Bougie

Interventions

To compare combined video laryngoscopy and bougie versus direct laryngoscopy and bougie for nasal intubation.

To compare combined video laryngoscopy and bougie versus direct laryngoscopy and bougie for nasal intubation

Group ΙI Direct Laryngoscopy (DL) and Bougie :

Eligibility Criteria

Age18 Years - 70 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Patients who will undergo maxillofacial surgeries with nasotracheal intubation..
  • ASA I/II patients.
  • BMI \<35

You may not qualify if:

  • Having bleeding diathesis and abnormal Prothrombin Time (PT), Partial Thromboplastin Time (PTT), or platelet counts.
  • Local causes of bleeding as adenoid
  • On medications that alter blood coagulation as anticoagulants and antiplatlets.
  • Patients in which either intubation failed on both nostrils or where intubation was only possible with a tube smaller than 6.0 mm internal diameter(ID).
  • Anticipated difficult airways.
  • ASA III/IV.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Aswan University

Aswān, Aswan Governorate, 81528, Egypt

RECRUITING

Related Publications (4)

  • Nedrud SM, Baasch DG, Cabral JD, McEwen DS, Dasika J. Combined Video Laryngoscope and Fiberoptic Nasal Intubation. Cureus. 2021 Nov 11;13(11):e19482. doi: 10.7759/cureus.19482. eCollection 2021 Nov.

    PMID: 34912623BACKGROUND
  • Kumar P, Sharma J, Johar S, Singh V. Guiding Flexible-Tipped Bougie Under Videolaryngoscopy: An Alternative to Fiberoptic Nasotracheal Intubation in Maxillofacial Surgeries. J Maxillofac Oral Surg. 2020 Jun;19(2):324-326. doi: 10.1007/s12663-020-01327-w. Epub 2020 Jan 24.

    PMID: 32346248BACKGROUND
  • Prasant MC, Kar S, Rastogi S, Hada P, Ali FM, Mudhol A. Comparative Study of Blood Loss, Quality of Surgical Field and Duration of Surgery in Maxillofacial Cases with and without Hypotensive Anesthesia. J Int Oral Health. 2014 Nov-Dec;6(6):18-21.

    PMID: 25628477BACKGROUND
  • Eldemrdash AM, Alazhary MA, Zaher ZZ, Hemaida TS, Yahia ME, Hammad SS. Comparison of Nasal and Oropharyngeal Bleeding in Video Laryngoscopy Versus Direct Laryngoscopy for Nasotracheal Intubation in Maxillofacial Trauma: A Randomized Controlled Trial. Anesthesiol Res Pract. 2025 Jul 3;2025:7797828. doi: 10.1155/anrp/7797828. eCollection 2025.

MeSH Terms

Conditions

Maxillofacial InjuriesEpistaxis

Condition Hierarchy (Ancestors)

Facial InjuriesCraniocerebral TraumaTrauma, Nervous SystemNervous System DiseasesWounds and InjuriesNose DiseasesRespiratory Tract DiseasesOtorhinolaryngologic DiseasesHemorrhagePathologic ProcessesPathological Conditions, Signs and SymptomsSigns and Symptoms, RespiratorySigns and Symptoms

Study Officials

  • Mohammed A Alazhary, MD

    Aswan University

    PRINCIPAL INVESTIGATOR
  • Ayman M Eldemrdash, MD

    Aswan University

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Soudy S Hammad, MD

CONTACT

Mohammed E Yahia, MSc

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
PREVENTION
Intervention Model
PARALLEL
Model Details: These prospective, randomized, controlled clinical trials will be conducted at Aswan University Hospital on 62 patients who are scheduled for maxillofacial surgeries requiring nasal intubation.
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Lecturer of anesthesia and surgical intensive care

Study Record Dates

First Submitted

April 4, 2024

First Posted

April 26, 2024

Study Start

June 1, 2024

Primary Completion

January 1, 2025

Study Completion

March 1, 2025

Last Updated

February 21, 2025

Record last verified: 2024-05

Data Sharing

IPD Sharing
Will not share

Locations